| Hepatocellular carcinoma immunotherapy RC Sperandio, RC Pestana, BV Miyamura, AO Kaseb Annual review of medicine 73, 267-278, 2022 | 105 | 2022 |
| EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature RC Sperandio, FLT Tostes, PV Campregher, VR Paes, F Moura, ... Lung Cancer 166, 94-97, 2022 | 6 | 2022 |
| The gut microbiome and metastatic renal cell carcinoma L Meza, M Feng, K Lee, R Sperandio, SK Pal Journal of Clinical Medicine 12 (4), 1502, 2023 | 5 | 2023 |
| Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy R Barragan-Carrillo, A Govindarajan, A Rock, RC Sperandio, SK Pal Hematology/Oncology Clinics 37 (5), 965-976, 2023 | 3 | 2023 |
| Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies A Shiner, RC Sperandio, M Naimi, U Emmenegger Journal of Clinical Medicine 13 (3), 734, 2024 | 1 | 2024 |
| A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) FSM Monteiro, A Soares, VC Souza, RC Sperandio, E Grande, M Santoni, ... Clinical Genitourinary Cancer 20 (5), 391-398, 2022 | 1 | 2022 |
| Neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer (NSCLC): A systematic review and extracted individual patient data meta-analysis. MT Trinconi Cunha, RC Sperandio, KK Chan, IB Menjak Journal of Clinical Oncology 42 (16_suppl), 8045-8045, 2024 | | 2024 |
| Toxicity-benefit analysis of advanced prostate cancer trials using weighted toxicity scoring. JK Gill, RC Sperandio, TH Nguyen, U Emmenegger Journal of Clinical Oncology 42 (4_suppl), 110-110, 2024 | | 2024 |
| Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported Outcomes R Epistola, R Sperandio, Z Wainberg, S Iqbal, J Chao Cancer Management and Research, 265-275, 2023 | | 2023 |
| Vascular Surgery and Medical Oncology RC Sperandio, G Schvartsman Vascular Surgery in Oncology, 347-363, 2022 | | 2022 |
| Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma RC Sperandio, RC Pestana, AO Kaseb The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato …, 2022 | | 2022 |
